I asked DewDiligence (moderator of Biotech Values) why Dr. B resigned. DewDiligence owns RVNC and knows pretty much everything about that company.
His answer:
"Based on the timing of the resignation and on Dr. Bertolino's background in dermatology, I suspect that the discontinuation of RT001 (the topical botulinum toxin) was the impetus."